Radicava Will Be a New Specialty Med for Lou Gehrig's Disease

Radicava (ra-dih-CAH-vah, edaravone) is the first med approved for Lou Gehrig's disease, or ALS, in almost 20 years. ...

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote